Compare ALAR & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALAR | VNRX |
|---|---|---|
| Founded | 2013 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1M | 38.2M |
| IPO Year | 2018 | N/A |
| Metric | ALAR | VNRX |
|---|---|---|
| Price | $7.61 | $0.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $27.00 | $3.17 |
| AVG Volume (30 Days) | 91.6K | ★ 2.8M |
| Earning Date | 11-26-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $36,305,000.00 | $1,472,007.00 |
| Revenue This Year | $31.17 | $55.33 |
| Revenue Next Year | $30.14 | $493.79 |
| P/E Ratio | $47.06 | ★ N/A |
| Revenue Growth | ★ 15.03 | 14.48 |
| 52 Week Low | $5.45 | $0.27 |
| 52 Week High | $18.00 | $0.94 |
| Indicator | ALAR | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 18.61 | 31.94 |
| Support Level | $7.72 | $0.28 |
| Resistance Level | $9.35 | $0.31 |
| Average True Range (ATR) | 0.49 | 0.03 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 0.23 | 3.40 |
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.